Longitudinal Cohort Investigation of Mild Bilirubin-Related Biochemical Liver Changes Following SARS-CoV-2 Infection in a Specific Group of Wilson’s Disease Patients with Liver Cirrhosis - Takeaways - MDSpire

Longitudinal Cohort Investigation of Mild Bilirubin-Related Biochemical Liver Changes Following SARS-CoV-2 Infection in a Specific Group of Wilson’s Disease Patients with Liver Cirrhosis

  • By

  • Sebastian Köhrer

  • Maximilian Lukas Brand

  • Viola Leidner

  • Holger Zimmer

  • Andrea Langel

  • Jessica Langel

  • Patrick Michl

  • Isabelle Mohr

  • April 20, 2026

  • 0 min

Share

  • 1

    Wilson’s Disease is an autosomal recessive disorder characterized by impaired hepatic copper elimination and systemic copper accumulation.

  • 2

    Patients with chronic liver disease, especially cirrhosis, are at increased risk for severe outcomes from SARS-CoV-2 infection.

  • 3

    The study analyzed biochemical liver changes in Wilson’s Disease patients before and after SARS-CoV-2 infection.

  • 4

    71 out of 192 eligible Wilson’s Disease patients had complete follow-up data for assessing liver function post-infection.

  • 5

    Understanding the long-term effects of COVID-19 on liver function in Wilson’s Disease is crucial for patient management.

Original Source(s)

Related Content